← Back to all trials
Not Yet Recruiting
NCT07657442
Risk-Stratified Hypofractionated Radiotherapy After Breast-Conserving Surgery for Early Breast Cancer
Conditions: Early Stage Breast Carcinoma, Breast Cancer
Sex: Female
Ages: 18 Years – 75 Years
Healthy volunteers: No
Phase: NA
Enrollment: 649
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Location: Cancer Hospital, Chinese Academy of Medical Sciences Beijing Beijing Municipality
Summary
This prospective study is designed to evaluate the feasibility, efficacy, and safety of risk-stratified hypofractionated radiotherapy after breast-conserving surgery in patients with early breast cancer.
Eligibility Criteria
Inclusion Criteria:
* ECOG performance status score of 0 to 2.
* Pathologically confirmed breast cancer, including invasive carcinoma or ductal carcinoma in situ.
* Clinical stage cT0-2N0M0.
* Underwent breast-conserving surgery.
* Negative surgical margins greater than 2 mm.
Exclusion Criteria:
* Regional lymph node metastasis.
* Distant metastasis.
* Bilateral breast cancer.
* Prior thoracic radiotherapy.
* Life expectancy of less than 5 years.
* Lactating or pregnant women.
Source: ClinicalTrials.gov (NCT07657442). StuddyBuddy aggregates publicly available trial information.
